Results 1 - 25 from 71 for "biofarm"
-
Biofarm Proposes Shareholders RON29.7M Dividends from 2022 Profit
03.21.2023
Pharmaceutical producer Biofarm (BIO.RO) has called shareholders for April 26, 2023 to approve distribution of the 2022 net profit and of the RON0.03 per share gross dividend, reports to the more
-
Biofarm Reports RON70.9M Net Profit For 2022, Up 18% YoY
02.27.2023
Drug manufacturer Biofarm (BIO.RO) on Monday (Feb 27) reported a turnover of RON277 million for 2022, up 16% from 2021, and a net profit of RON70.9 million, up 18% on the year. more
-
Biofarm Posts 20% Higher Net Profit and 17% Higher Sales in Jan-Sep
11.14.2022
Drug manufacturer Biofarm (BIO.RO) recorded a net profit of RON65.7 million in the first nine months of 2022, an increase of 20% on the previous year, according to ZF calculations based on data more
-
Biofarm Invests EUR44M In Its New Production Unit Inaugurated In Bucharest In 2021
09.30.2022
Pharmaceutical manufacturer Biofarm (BIO.RO) has reached total investments of over EUR44 million in its new plant inaugurated in capital Bucharest in 2021, which is the largest greenfield investment more
-
Biofarm Seeks 16% Growth in Revenue and 10% Higher Profit in 2022
03.28.2022
Pharmaceutical manufacturer Biofarm (BIO.RO) expects 16% higher revenue compared with RON239 million of 2021, as well as 15% higher EBITDA from about RON82 million last year. more
-
Biofarm Aims to Double Turnover in 5-7 Years
03.24.2022
Romanian drug maker Biofarm, a major player on the local market, plans to double turnover within the next 5-7 years after having opened a new drug plant in Bucharest last year in the wake of EUR35 more
-
Biofarm Sales Up 10% To RON239M, Net Profit Up 11% To RON60M YoY In 2021
02.28.2022
Romanian pharmaceutical products manufacturer Biofarm (BIO.RO) on Monday said it ended 2021 with a turnover of RON239 million, up 10% on the year, and a net profit of RON60 million, up 11% from 2020. more
-
Biofarm Bets on New Internally-Developed Products
01.06.2022
Romanian-held pharmaceutical products manufacturer Biofarm, the fifth largest player on this market by turnover, plans to add internally-developed products to its portfolio, especially as the company more
-
Biofarm Plans to Double Turnover in 5-10 Years
11.23.2021
Pharmaceutical manufacturer Biofarm Bucuresti plans to double turnover and focus more on exports in the coming years, according to Catalin Vicol, the company’s general manager. more
-
Biofarm Inaugurates Second Drug Plant In Bucharest In Over EUR35M Investment
11.02.2021
Pharmaceutical manufacturer Biofarm (BIO.RO) has inaugurated a new pharmaceutical manufacturing and testing facility in capital Bucharest, which entailed an investment of over EUR35 million. more
-
Biofarm Sees 8% Turnover Growth, 15% Profit Increase In 2017-2020 Period
10.27.2021
Romanian pharmaceutical company Biofarm Bucuresti (BIO.RO) on Wednesday said it registered an aggregate growth of 8% in turnover and of 15% in profit during 2017 – 2020 period. more
-
Pharmaceutical Manufacturer Biofarm Earmarks EUR10M for Investments in 2021
04.29.2021
Pharmaceutical manufacturer Biofarm (BIO.RO) has budgeted RON47.4 million (almost EUR10 million) for investments in 2021, most of which or about 70% will go towards equipping the new production more
-
Biofarm Cleared for RON21.7M Dividend Payout
04.26.2021
Shareholders of Romanian pharmaceutical company Biofarm Bucuresti (BIO.RO) on Monday approved the company's plans to distribute dividends totaling RON21.7 million. more
-
Biofarm Targets 15% Growth in Turnover in 2021, to RON250M
03.23.2021
Romanian pharmaceutical company Biofarm Bucuresti (BIO.RO) estimates its turnover will grow 15% in 2021 compared with 2020, to over RON250 million. more
-
Biofarm Net Profit Up 7.2% To RON54M, Sales Revenue Up 8% To RON218M YoY In 2020
02.16.2021
Biofarm Bucuresti (BIO.RO), one of the leading drugmakers in Romania, ended 2020 with a net profit of RON54.5 million, up 7.2% versus 2019, while income from sales grew 8% to RON218 million, the more
-
Marian Buica Elected Temporary Member Of Biofarm Board Of Directors
09.18.2020
Marian Buica, general manager of regional investment fund SIF Muntenia (SIF4.RO), was elected temporary member of the Board of Directors of pharmaceuticals company Biofarm, Bucuresti and is to be more
-
Biofarm Posts RON30M Net Profit in H1
08.17.2020
Pharmaceutical company Biofarm Bucuresti (BIO.RO) posted 29.8 million lei net profit in the first half, 6% higher than in the year-ago period, while revenue stood at RON106 million, up from the RON97 more
-
Biofarm Seeks To Pay Gross Dividends Of RON0.021/Share From 2019 Net Profit, At 6.3% Yield
03.24.2020
-
Biofarm Shareholders Approve Additional Dividends of RON9.8M
12.11.2019
Shareholders of pharmaceutical producer Biofarm (BIO.RO) on Wednesday approved additional dividends of RON0.01 per share, amounting to RON9.8 million. more
-
Biofarm Investments Exceed RON10M In January-June 2019
08.14.2019
-
SIF Moldova Sells All Its Shares In Biofarm To SIF Banat-Crisana
05.24.2019
-
Biofarm Net Profit Grows 46% in 1Q, to RON16.2M
05.15.2019
Romanian pharmaceutical producer Biofarm (BIO.RO) on Wednesday reported a net profit of RON16.2 million for the first quarter, up 46% compared with the same period last year. more
-
Biofarm Appoints Catalin Vicol as General Manager Starting Nov 15
09.13.2018
Romanian pharmaceutical producer Biofarm (BIO.RO), controlled by three regional investment funds, of SIFs, has appointed Catalin Vicol as general manager effective November 15. more
-
Biofarm Proposes RON18.7M Dividends At 6% Yield
03.14.2018
Romanian pharmaceutical producer Biofarm (BIO.RO) proposes the payment of a gross dividend of RON0.019 per share, at a 6.16% yield, totaling RON18.7 million, which translates into a distribution rate more
-
Biofarm 2017 Turnover Up 12% At RON170M; Net Profit Up 24% At RON36M
01.31.2018